NasdaqGS - Delayed Quote • USD
Sinovac Biotech Ltd. (SVA)
At close: April 4 at 4:00 PM EDT
Key Executives
Key Executives Information Not Available
Sinovac Biotech Ltd.
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
Sinovac Biotech Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
- Feb 21, 20248-A12B/A: Trading RegistrationsSee Full Filing
- Jan 18, 2024SC 14D9: Tender Offer/Acquisition ReportsSee Full Filing
- Dec 04, 2023SC 13D/A: Tender Offer/Acquisition ReportsSee Full Filing
- Oct 05, 2023CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submissionSee Full Filing
- Sep 15, 2023SC 13D/A: Tender Offer/Acquisition ReportsSee Full Filing
Upcoming Events
Upcoming Events Information Not Available
Related Tickers
HSTC HST Global, Inc.
1.1100
+18.09%
688136.SS Kexing Biopharm Co., Ltd.
15.28
+0.73%
YECO EV Biologics, Inc.
0.6221
+3.32%
LIPO Lipella Pharmaceuticals Inc.
0.7110
+0.98%
ACHL Achilles Therapeutics plc
0.7600
-2.69%
FBRX Forte Biosciences, Inc.
0.7163
-0.07%
XCUR Exicure, Inc.
0.5001
-1.56%
SVA.TO Sernova Corp.
0.4400
+3.53%
SXTP 60 Degrees Pharmaceuticals, Inc.
0.2376
-0.50%
CMMB Chemomab Therapeutics Ltd.
0.6399
-2.90%